Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Change in Acquisitions & Divestments (2016 - 2017)

Historic Change in Acquisitions & Divestments for Adma Biologics (ADMA) over the last 2 years, with Q2 2017 value amounting to $245000.0.

  • Adma Biologics' Change in Acquisitions & Divestments rose 10666.99% to $245000.0 in Q2 2017 from the same period last year, while for Mar 2018 it was $245000.0, marking a year-over-year decrease of 9864.86%. This contributed to the annual value of $5.4 million for FY2017, which is 6764.21% down from last year.
  • Per Adma Biologics' latest filing, its Change in Acquisitions & Divestments stood at $245000.0 for Q2 2017, which was up 10666.99% from $5.1 million recorded in Q1 2017.
  • Adma Biologics' 5-year Change in Acquisitions & Divestments high stood at $16.7 million for Q4 2016, and its period low was -$3.7 million during Q2 2016.